| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.88▼ | 1.88▼ | 1.87▼ | 1.85▲ | 1.93▼ |
| MA10 | 1.88▼ | 1.87▼ | 1.87▲ | 1.82▲ | 2.80▼ |
| MA20 | 1.87▼ | 1.87▲ | 1.86▲ | 1.94▼ | 3.72▼ |
| MA50 | 1.86▲ | 1.85▲ | 1.83▲ | 2.97▼ | 9.01▼ |
| MA100 | 1.83▲ | 1.84▲ | 1.91▼ | 3.84▼ | 287.73▼ |
| MA200 | 1.84▲ | 2.12▼ | 2.48▼ | 5.94▼ | 346.76▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.001▲ | 0.001▲ | 0.078▲ | 1.573▲ |
| RSI | 50.399▲ | 51.676▲ | 53.027▲ | 36.413▼ | 31.932▼ |
| STOCH | 64.286 | 62.290 | 56.061 | 65.403 | 10.108▼ |
| WILL %R | -60.000 | -50.000 | -50.000 | -35.714 | -85.143▼ |
| CCI | -19.198 | -3.636 | 26.300 | 85.901 | -93.983 |
|
Thursday, September 24, 2026 05:30 AM
Company Making Critical Progress in Scalable Manufacturing and Preparing the Lead Trispecific Candidate for Future Human TestingTrispecifics Combine Three Complementary Cancer-Fighting Functions in ...
|
|
Monday, August 24, 2026 02:02 AM
Aptevo Therapeutics, Inc. (NASDAQ: APVO) is currently focused on the continued clinical progress with mipletamig, a $1.5 million non-dilutive grant to advance APVO451, and the company's recently ...
|
|
Tuesday, June 16, 2026 06:24 AM
We are initiating coverage of Aptevo Therapeutics Inc. (NASDAQ: APVO) with a valuation of $30.00. Aptevo is a clinical-stage biotechnology company developing multispecific immunotherapies designed to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/26 | 1.83 | 1.90 | 1.818 | 1.89 | 25,369 |
| 24/09/26 | 1.88 | 1.90 | 1.81 | 1.83 | 32,966 |
| 23/09/26 | 1.88 | 1.895 | 1.8001 | 1.89 | 51,906 |
| 22/09/26 | 1.8135 | 1.89 | 1.8135 | 1.85 | 39,202 |
| 21/09/26 | 1.8423 | 1.89 | 1.8047 | 1.81 | 22,347 |
| 18/09/26 | 1.85 | 1.8899 | 1.82 | 1.84 | 40,797 |
| 17/09/26 | 1.79 | 1.90 | 1.73 | 1.84 | 423,829 |
| 16/09/26 | 1.7105 | 1.80 | 1.7105 | 1.72 | 53,965 |
| 15/09/26 | 1.81 | 1.84 | 1.71 | 1.71 | 48,827 |
| 14/09/26 | 1.8538 | 1.895 | 1.80 | 1.80 | 46,080 |
|
|
||||
|
|
||||
|
|